These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7051465)

  • 21. Pre-transplant blood transfusion and renal allograft outcome: a report of the North American Pediatric Renal Transplant Cooperative Study.
    Chavers BM; Sullivan EK; Tejani A; Harmon WE
    Pediatr Transplant; 1997 Aug; 1(1):22-8. PubMed ID: 10084783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update of the University of California at San Francisco experience with donor-specific blood transfusions.
    Salvatierra O; Iwaki Y; Vincenti F; Amend W; Terasaki P; Garovoy M; Duca R; Hopper S; Feduska N
    Transplant Proc; 1982 Jun; 14(2):363-6. PubMed ID: 7051480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent developments in HLA typing.
    Duquesnoy RJ
    Prog Clin Biol Res; 1982; 88():125-42. PubMed ID: 6808523
    [No Abstract]   [Full Text] [Related]  

  • 24. Does re-exposure to mismatched HLA antigens decrease renal re-transplant allograft survival?
    Farney AC; Matas AJ; Noreen HJ; Reinsmoen N; Segall M; Schmidt WJ; Gillingham K; Najarian JS; Sutherland DE
    Clin Transplant; 1996 Apr; 10(2):147-56. PubMed ID: 8664509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The UNOS Scientific Renal Transplant Registry--ten years of kidney transplants.
    Cecka JM
    Clin Transpl; 1997; ():1-14. PubMed ID: 9919387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of transfusion on recipient immune status: relationship to transplantation.
    Kahan BD
    Prog Clin Biol Res; 1985; 182():345-74. PubMed ID: 2994107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Living donor transplants.
    Cecka JM
    Clin Transpl; 1995; ():363-77. PubMed ID: 8794280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The UNOS Scientific Renal Transplant Registry.
    Cecka JM
    Clin Transpl; 1999; ():1-21. PubMed ID: 11038622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients.
    Jordan SC; Vo A; Bunnapradist S; Toyoda M; Peng A; Puliyanda D; Kamil E; Tyan D
    Transplantation; 2003 Aug; 76(4):631-6. PubMed ID: 12973100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors on graft survival of living donor kidney transplantation.
    Park YH; Min SK; Lee JN; Lee HH; Jung WK; Lee JS; Lee JH; Lee YD
    Transplant Proc; 2004 Sep; 36(7):2023-5. PubMed ID: 15518732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The putative mechanism of the immunomodulating effect of HLA-DR shared allogeneic blood transfusions on the alloimmune response.
    Waanders MM; Roelen DL; Brand A; Claas FH
    Transfus Med Rev; 2005 Oct; 19(4):281-7. PubMed ID: 16214017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome.
    Worthington JE; Martin S; Al-Husseini DM; Dyer PA; Johnson RW
    Transplantation; 2003 Apr; 75(7):1034-40. PubMed ID: 12698094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A model for human leukocyte antigen-matched donor-swap transplantation in India.
    Basu G; Daniel D; Rajagopal A; Neelakantan N; John GT
    Transplantation; 2008 Mar; 85(5):687-92. PubMed ID: 18337661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Living donor kidney transplantation: the effects of donor age and gender on short- and long-term outcomes.
    Øien CM; Reisaeter AV; Leivestad T; Dekker FW; Line PD; Os I
    Transplantation; 2007 Mar; 83(5):600-6. PubMed ID: 17353781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [HLA typing in high risk keratoplasty].
    Hirsch N; Nölle B; Zavazava N; Westphal E; Duncker G; Rochels R; Müller-Ruchholtz W
    Ophthalmologe; 1993 Apr; 90(2):174-7. PubMed ID: 8490302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors on graft survival of living donor kidney transplantation in a single center.
    Jin DC; Yoon YS; Kim YS; Yoon SA; Ahn SJ; Kim SY; Chang YS; Bang BK; Koh YB
    Clin Transplant; 1996 Dec; 10(6 Pt 1):471-7. PubMed ID: 8996765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitization 2001.
    Hardy S; Lee SH; Terasaki PI
    Clin Transpl; 2001; ():271-8. PubMed ID: 12211790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Re-exposure to mismatched HLA class I is a significant risk factor for graft loss: multivariable analysis of 259 kidney retransplants.
    House AA; Chang PC; Luke PP; Leckie SH; Howson WT; Ball EJ; Tan AK; Rehman F; Muirhead N; Hollomby DJ; McAlister VC; Hodsman AB; Jevnikar AM
    Transplantation; 2007 Sep; 84(6):722-8. PubMed ID: 17893605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.